BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15745889)

  • 21. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years--United States, 2004-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(39):1065-8. PubMed ID: 17021591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance.
    Opstelten W; Hak E; Verheij TJ; van Essen GA
    Am J Med; 2001 Oct; 111(6):474-9. PubMed ID: 11690574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states.
    Shefer A; McKibben L; Bardenheier B; Bratzler D; Roberts H
    J Am Med Dir Assoc; 2005; 6(2):97-104. PubMed ID: 15871883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-system pharmacists' role in immunizing adults against pneumococcal disease and influenza.
    Grabenstein JD; Bonasso J
    Am J Health Syst Pharm; 1999 Sep; 56(17 Suppl 2):S3-22; quiz S23-4. PubMed ID: 10512518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of a vaccine screening program at an independent community pharmacy.
    Rhodes LA; Branham AR; Dalton EE; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(2):222-228. PubMed ID: 27964886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia.
    Lara C; De Graeve D; Franco F
    Value Health Reg Issues; 2018 Dec; 17():21-31. PubMed ID: 29626706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Inpatient Influenza and Pneumococcal Vaccination Acceptance Rates With Pharmacist Education.
    Queeno BV
    J Pharm Pract; 2017 Apr; 30(2):202-208. PubMed ID: 26880320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of adult vaccination at inner-city health centers: a descriptive study.
    Nowalk MP; Zimmerman RK; Tabbarah M; Raymund M; Jewell IK
    BMC Fam Pract; 2006 Jan; 7():2. PubMed ID: 16403215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacist-run influenza immunization clinic for health workers.
    Sanchez D; Breland BD; Pinkos L; Eagle A; Nowlin D; Duty L
    Am J Health Syst Pharm; 2003 Feb; 60(3):241-3. PubMed ID: 12613232
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and trend in the use of hospital-based standing orders programs for influenza and pneumococcal vaccination.
    Pentakota SR; Halperin W
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):899-904. PubMed ID: 17620234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient experiences with influenza immunizations administered by pharmacists.
    Isenor JE; Wagg AC; Bowles SK
    Hum Vaccin Immunother; 2018 Mar; 14(3):706-711. PubMed ID: 29303681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of pharmacist administration of influenza vaccines on uptake in Canada.
    Buchan SA; Rosella LC; Finkelstein M; Juurlink D; Isenor J; Marra F; Patel A; Russell ML; Quach S; Waite N; Kwong JC;
    CMAJ; 2017 Jan; 189(4):E146-E152. PubMed ID: 27503864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients with Asthma or COPD.
    Klassing HM; Ruisinger JF; Prohaska ES; Melton BL
    J Community Health; 2018 Apr; 43(2):297-303. PubMed ID: 28852915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pharmacists in the delivery of influenza vaccinations.
    Steyer TE; Ragucci KR; Pearson WS; Mainous AG
    Vaccine; 2004 Feb; 22(8):1001-6. PubMed ID: 15161077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal vaccination in hospitalized elderly patients: role of the pharmacist.
    Wong-Beringer A; Brodetsky E; Quist R
    Pharmacotherapy; 2003 Feb; 23(2):199-208. PubMed ID: 12587809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of standing orders programs to increase adult vaccination rates.
    McKibben LJ; Stange PV; Sneller VP; Strikas RA; Rodewald LE;
    MMWR Recomm Rep; 2000 Mar; 49(RR-1):15-6. PubMed ID: 15580727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.
    Han J; Bhat S; Gowhari M; Gordeuk VR; Saraf SL
    Pharmacotherapy; 2016 Nov; 36(11):1166-1172. PubMed ID: 27639254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving inpatient pneumococcal and influenza vaccination rates.
    Rees S; Stevens L; Drayton J; Engledow N; Sanders J
    J Nurs Care Qual; 2011; 26(4):358-63. PubMed ID: 21577146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KePRO priming for adult vaccination campaign.
    Oh J
    Pa Med; 1999 Nov; 102(11):6. PubMed ID: 11392854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.